Early Stage Partners provides early stage venture capital financing to the Midwest’s most promising entrepreneurial companies in:

  • Technology
  • Life Sciences
  • Advanced Materials
  • Instruments, Controls & Electronics
  • Cleantech

 

 

Mission

Mission

Early Stage Partners was formed in 2001 with the belief that the Midwest would create and attract a significant number of companies that would be attractive early stage venture capital investments.

Since then, that belief has been borne out. The Midwest is in the midst of a surge of entrepreneurial energy that is generating high quality technologies and companies. We are pleased to work with the region’s leading entrepreneurs to provide financing, advice, and access to value-added networks.

With a track record of successful investing, ESP is now investing from Fund II.

Find Out More About ESP

News & Events

OnShift Closes $3 Million Series B Early Stage Capital Investment

February 01, 2012
Company, which quadrupled revenue in 2011, plans to double head count in 2012.

Reverse Medical Sells Neurovascular Guide Catheter Business

January 23, 2012
Proceeds will help fund other thrombectomy and neurovascular technologies.

CytoPherx Raises $34 Million Early Stage Venture Capital Round

January 04, 2012
Early Stage Partners structured a funding for company focused on acute kidney injury

OnShift Scores In Customer Ratings Survey

January 03, 2012
100% of OnShift customers said they would buy again.